Design and synthesis of a novel dipeptide mimetic of the 4th loop of neurotrophin-3 and its pharmacological effects

被引:1
|
作者
Tarasiuk, Alexey, V [1 ]
Sazonova, Nellya M. [1 ]
V. Melnikova, Marina [1 ]
V. Pomogaybo, Sergey [1 ]
Logvinov, Ilya O. [1 ]
Nikolaev, Sergey, V [1 ]
Nikiforov, Dmitry M. [1 ]
Antipova, Tatiana A. [1 ]
Povarnina, Polina Yu. [1 ]
Vakhitova, Yulia V. [1 ]
Gudasheva, Tatiana A. [1 ]
Seredenin, Sergey B. [1 ]
机构
[1] VV Zakusov Res Inst Pharmacol, Moscow 125315, Russia
关键词
dipeptide mimetic; low-molecular mimetic; design; neurotrophin-3; cytoprotective activity; antidepressant-like activity; TRKA;
D O I
10.1016/j.mencom.2023.10.016
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A novel neurotrophin-3 loop 4 dipeptide mimetic, bis(N-y-hydroxybutyryl-l-glutamyl-l-asparagine) hexamethylenedi-amide (GTS-302), was designed and synthesized. Compound GTS-302 activated the tyrosine kinase receptors TrkC and TrkB, exhibited cytoprotective activity (10-8-10-5 M) in oxidative stress model in HT-22 cells and in 6-hydroxy-dopamine-induced SH-SY5Y cell damage. It also demon-strated an antidepressant-like activity in the forced swim test in mice (0.5-10.0 mg kg-1, intraperitoneally).
引用
收藏
页码:786 / 789
页数:4
相关论文
共 36 条
  • [31] Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one(TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model
    Tamaoki, Satoru
    Yamauchi, Yukinao
    Nakano, Youichi
    Sakano, Sayuri
    Asagarasu, Akira
    Sato, Michitaka
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 322 (03): : 1315 - 1323
  • [32] STUDIES ON NEUROKININ ANTAGONISTS .4. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL DIPEPTIDE SUBSTANCE-P ANTAGONISTS - N-2-[(4R)-4-HYDROXY-1-[(1-METHYL-1H-INDOL-3-YL)CARBONYL]-L-PROLYL]-N-METHYL-N-(PHENYLMETHYL)-3-(2-NAPHTHYL)-L-ALANINAMIDE AND ITS RELATED-COMPOUNDS
    HAGIWARA, D
    MIYAKE, H
    IGARI, N
    KARINO, M
    MAEDA, Y
    FUJII, T
    MATSUO, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (13) : 2090 - 2099
  • [33] Design, Synthesis, and Pharmacological Characterization of N- and O-Substituted 5,6,7,8-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol Analogues: Novel 5-HT2A/5-HT2C Receptor Agonists with Pro-Cognitive Properties
    Jensen, Anders A.
    Plath, Niels
    Pedersen, Martin H. F.
    Isberg, Vignir
    Krall, Jacob
    Wellendorph, Petrine
    Stensbol, Tine B.
    Gloriam, David E.
    Krogsgaard-Larsen, Povl
    Frolund, Bente
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (03) : 1211 - 1227
  • [34] Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): Effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras
    Tejada, Frederick R.
    Nagy, Peter I.
    Xu, Min
    Wu, Cindy
    Katz, Tricia
    Dorsey, Jason
    Rieman, Melissa
    Lawlor, Elizabeth
    Warrier, Manya
    Messer, William S., Jr.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (25) : 7518 - 7531
  • [35] Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress
    Aiello, Francesca
    Badolato, Mariateresa
    Pessina, Federica
    Sticozzi, Claudia
    Maestrini, Vanessa
    Aldinucci, Carlo
    Luongo, Livio
    Guida, Francesca
    Ligresti, Alessia
    Artese, Anna
    Allara, Marco
    Costa, Giosue
    Frosini, Maria
    Moriello, Aniello Schiano
    De Petrocellis, Luciano
    Valacchi, Giuseppe
    Alcaro, Stefano
    Maione, Sabatino
    Di Marzo, Vincenzo
    Corelli, Federico
    Brizzi, Antonella
    ACS CHEMICAL NEUROSCIENCE, 2016, 7 (06): : 737 - 748
  • [36] Azaxanthene Based Selective Glucocorticoid Receptor Modulators: Design, Synthesis, and Pharmacological Evaluation of (S)-4-(5-(1-((1,3,4-Thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and Its Methylene Homologue (BMS-791826)
    Weinstein, David S.
    Gong, Hua
    Doweyko, Arthur M.
    Cunningham, Mark
    Habte, Sium
    Wang, Jin Hong
    Holloway, Deborah A.
    Burke, Christine
    Gao, Ling
    Guarino, Victor
    Carman, Julie
    Somerville, John E.
    Shuster, David
    Salter-Cid, Luisa
    Dodd, John H.
    Nadler, Steven G.
    Barrish, Joel C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) : 7318 - 7333